What is NDC 25021-192?

25021-192 is the product NDC for Ciprofloxacin, Ciprofloxacin 2 mg/mL injection, solution, listed with the FDA by Sagent Pharmaceuticals. It has 2 package NDCs, shown above in 10- and 11-digit form.

Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ciprofloxacin?

168 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ciprofloxacin NDC 25021-192 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-192Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0192Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
25021-192-82	25021019282	24 POUCH in 1 CARTON (25021-192-82) / 1 BAG in 1 POUCH / 100 mL in 1 BAGMarketed from Dec 15, 2022
25021-192-87	25021019287	24 POUCH in 1 CARTON (25021-192-87) / 1 BAG in 1 POUCH / 200 mL in 1 BAGMarketed from Dec 15, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ciprofloxacin
Generic name (nonproprietary): ciprofloxacin
Active ingredients: Ciprofloxacin — 2 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Sagent PharmaceuticalsNDC labeler code 25021
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078252
Marketing start: Dec 15, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 1A2 Inhibitors (Mechanism)Fluoroquinolones (Chemical structure)
Identifiers: Product ID 25021-192_60cceab7-7bcd-4340-b437-7ed68a26d581SPL ID 60cceab7-7bcd-4340-b437-7ed68a26d581SPL set ID f406e796-17d9-4465-b8a7-00d966a4ba74RxCUI 1665210, 1665212UNII 5E8K9I0O4UUPC 0325021192825
Pharmacologic class: Fluoroquinolone Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N425021019282 followed by a unit qualifier and the quantity

Package 25021-0192-82. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 4, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Ciprofloxacin Injection is a fluoroquinolone antibacterial indicated in adults (≥18 years of age) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: Skin and Skin Structure Infections ( 1.1 ) Bone and Joint Infections ( 1.2 ) Complicated Intra-Abdominal Infections ( 1.3 ) Nosocomial Pneumonia ( 1.4 ) Empirical Therapy for Febrile Neutropenic Patients ( 1.5 ) Inhalational Anthrax Post-Exposure in Adult and Pediatric Patients ( 1.6 ) Plague in Adult and Pediatric Patients ( 1.7 ) Chronic Bacterial Prostatitis ( 1.8 ) Lower Respiratory Tract Infections ( 1.9 ) Acute Exacerbation of Chronic Bronchitis Urinary Tract Infections ( 1.1…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 25021-192

What is NDC 25021-192?: 25021-192 is the product NDC for Ciprofloxacin, Ciprofloxacin 2 mg/mL injection, solution, listed with the FDA by Sagent Pharmaceuticals. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ciprofloxacin.
What is the active ingredient?: Ciprofloxacin.
Who is the labeler?: Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ciprofloxacin?: 168 other product NDCs are listed under this name. See all Ciprofloxacin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ciprofloxacin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ciprofloxacinciprofloxacin hydrochloride	Ciprofloxacin hydrochloride 500 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-947	60687-0947-01
ciprofloxacin	Ciprofloxacin hydrochloride 250 mg/1	Tablet, Film coatedOral	Northwind Health Company, LLC	82868-102	82868-0102-1482868-0102-20
ciprofloxacin	Ciprofloxacin hydrochloride 500 mg/1	Tablet, Film coatedOral	Cardinal Health 107, LLC	55154-0193	55154-0193-00
Ciprofloxacin	Ciprofloxacin hydrochloride 500 mg/1	Tablet, Film coatedOral	Direct_Rx	72189-627	72189-0627-1072189-0627-14
Ciprofloxacinciprofolxacin	Ciprofloxacin hydrochloride 250 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8875	68788-8875-0068788-8875-0168788-8875-02+4 more
Ciprofloxacin	Ciprofloxacin hydrochloride 500 mg/1	TabletOral	Direct_Rx	72189-623	72189-0623-1072189-0623-1472189-0623-20
Ciprofloxacin	Ciprofloxacin hydrochloride 250 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-690	60760-0690-10
Ciprofloxacinciprofloxacin hydrochloride	Ciprofloxacin hydrochloride 500 mg/1	Tablet, Film coatedOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8630	00615-8630-1000615-8630-1400615-8630-20
Ciprofloxacinciprofloxacin hydrochloride	Ciprofloxacin hydrochloride 500 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-977	59651-0977-0159651-0977-0559651-0977-20+2 more
Ciprofloxacinciprofloxacin hydrochloride	Ciprofloxacin hydrochloride 750 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-978	59651-0978-0159651-0978-0559651-0978-20+2 more

All 169 Ciprofloxacin NDCs

Other NDCs under ANDA 078252

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078252
Product	Strength	Form · route	Labeler	Product NDC
Ciprofloxacin	Ciprofloxacin 2 mg/mL	Injection, SolutionIntravenous	Sagent Pharmaceuticals	25021-114
Ciprofloxacin in Dextroseciprofloxacin	Ciprofloxacin 200 mg/100mL	Injection, SolutionIntravenous	Hospira, Inc.	0409-2300
Ciprofloxacin in Dextroseciprofloxacin	Ciprofloxacin 400 mg/200mL	Injection, SolutionIntravenous	Hospira, Inc.	0409-3300
Ciprofloxacin in Dextroseciprofloxacin	Ciprofloxacin 400 mg/200mL	Injection, SolutionIntravenous	ProPharma Distribution	84549-300